NITRIDERM TTS 15 mg/24 h, medicated transdermal patch 30 patches in individual sachets
Active ingredients: Nitroglycerin
Commercialized according to BDPMDispensing in France: Prescription only
Medicated transdermal patch30 patches in individual sachetstransdermique
No current ANSM shortage notice is included
Package details
Original BDPM fields are shown in French.
- Official name
- NITRIDERM TTS 15 mg/24 h, dispositif transdermique
- Pharmaceutical form
- dispositif
- Route of administration
- transdermique
- Presentation description
- 30 sachet(s) papier polyéthylène aluminium P-A-M-éthylène (SURLYN) de 1 dispositif(s)
- Marketing authorisation holder
- SANDOZ
- Reimbursement according to BDPM
- 65%
- Approval for use in healthcare institutions
- oui
- Commercialization declaration date
- 19 Mar 1997
- Prescription and dispensing conditions
- Prescription only
- List II: prescription-only medicine
- Enhanced ANSM monitoring
- No
BDPM identifiers
CIS
66838591CIP73407512CIP133400934075124Composition in BDPM
| Component | Amount per unit | Source type |
|---|---|---|
| TRINITRINEdispositif | 75 mg · un dispositif | SA |
Information is based on BDPM data and is for reference only. Consult a doctor before use.
Similar medicines
Similar medicines are listed using the official BDPM catalog. Availability must be checked separately. Consult a doctor or pharmacist before switching medicines.
The current BDPM data does not list similar medicines for this product.